Drug Pipeline

N-acetylcysteine Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
20
Active Studies
7
Recruiting
7
Phase 3
10
Top Sponsors
Active Studies by Phase
Phase 4
1
Phase 3
6
Phase 2/3
1
Phase 2
6
Phase 1/2
2
Phase 1
2
Early Phase 1
1
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT03652753 Pilon Fracture With Intra-articular Injection of N-Acetylcysteine (Pilon NAC) Pilon Fracture Recruiting
Phase 3
NCT07464886 Prefrontal Glutamatergic Modulation by NAC and MBCT for Depression in Youth Mild Depression Recruiting
NCT07325383 Safety and Efficacy of N-Acetylcysteine Mouthwash in Prevention of Mucositis in HSCT… Oral Mucositis Active, Not Recruiting
NCT07380347 Effect of N-acetylcysteine as Adjunct Therapy on the Clinical Outcome of Neonatal Sepsis Neonatal Sepsis Not Yet Recruiting
NCT07543458 Therapeutics for Moderate and Severe Dengue Dengue Not Yet Recruiting
NCT05537220 Oral N-acetylcysteine for Retinitis Pigmentosa Retinitis Pigmentosa Active, Not Recruiting
NCT02750319 Amiodarone and N-Acetylcysteine or Amiodarone Alone for Preventing Atrial Fibrillation… Thoracic Surgery Active, Not Recruiting
Phase 2/3
NCT05494398 Targeting the Neurobiology of RRB in Autism Using N-acetylcysteine: Open Label Autism Spectrum Disorder Enrolling by Invitation
Phase 2
NCT04278898 Targeting the Neurobiology of RRB in Autism Using N-acetylcysteine: Single-dose Autism Spectrum Disorder Recruiting
NCT07262554 N-acetylcysteine for Root Canal Treatment of Necrotic Teeth With Apical Periodontitis Apical Periodontitis Active, Not Recruiting
NCT04381897 Use of N-Acetylcysteine in the Treatment of Repetitive and Self-Injurious Behaviors in… Cornelia de Lange Syndrome Not Yet Recruiting
NCT05122559 Neuroprotection With N-acetyl Cysteine for Patients With Progressive Multiple Sclerosis Multiple Sclerosis Active, Not Recruiting
NCT00775476 Treatment of Systemic Lupus Erythematosus (SLE) With N-acetylcysteine Systemic Lupus Erythematosus Active, Not Recruiting
NCT04374461 A Study of N-acetylcysteine in Patients With COVID-19 Infection Covid-19 Active, Not Recruiting
Phase 1/2
NCT07414212 Evaluation of the Combined Therapy of EH-301 and N-acetylcysteine Together With Riluzole… Amyotrophic Lateral Sclerosis Recruiting
NCT05123365 An Optimal Dose Finding Study of N-Acetylcysteine in Patients With Myeloproliferative… Myeloproliferative Neoplasm Recruiting
Phase 1
NCT05241262 Study of N-acetylcysteine in the Treatment of Patients With the m.3243A>G Mutation and… Mitochondrial Disease Recruiting
NCT06260566 Tolerability of Enteral NAC in Infants Biliary Atresia Not Yet Recruiting
Early Phase 1
NCT07323446 The MIND Study: The MGH/MIT Investigation of NAC on Dysregulation Emotional Dysregulation Not Yet Recruiting
Not specified
NCT05294744 Utility of the Use of N-acetylcysteine Associated With Conventional Treatment in Patients… Alcoholic Hepatitis Recruiting
Sponsors Running N-acetylcysteine Trials
Disease Areas
Get alerts when N-acetylcysteine trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free